S
Susumu Kobayashi
Researcher at Beth Israel Deaconess Medical Center
Publications - 648
Citations - 23408
Susumu Kobayashi is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Total synthesis & Epidermal growth factor receptor. The author has an hindex of 62, co-authored 629 publications receiving 21514 citations. Previous affiliations of Susumu Kobayashi include Chiba University & University of Tokyo.
Papers
More filters
Journal ArticleDOI
Synthesis of a Potential Key Intermediate of Akaterpin, Specific Inhibitor of PI-PLC
Nobuyuki Kawai,Yuko Fujibayashi,Seiya Kuwabara,Ken Ichi Takao,Yasuharu Ijuin,Susumu Kobayashi +5 more
TL;DR: In this paper, a specific inhibitor of PI-PLC, cis-decalin 2 and transdecalin 3 were prepared, and a comparison of NMR spectra of 2 and 3 with those of akaterpin indicated that the upper decalin has a cis-fused structure.
Journal ArticleDOI
Transition-metal binding site of bleomycin. A synthetic analogue capable of binding Fe(II) to yield an oxygen-sensitive complex
Masami Otsuka,Makoto Yoshida,Susumu Kobayashi,Masaji Ohno,Yukio Sugiura,Tomohisa Takita,Hamao Umezawa +6 more
Journal ArticleDOI
Malignant melanoma originating on the female nipple: a case report.
Satoki Kinoshita,Kazuhisa Yoshimoto,Shigeya Kyoda,Hirano A,Hisashi Shioya,Susumu Kobayashi,Takaoki Ishiji,Kazumasa Komine,Hirosni Takeyama,Ken Uchida,Toshiaki Morikawa,Goi Sakamoto +11 more
TL;DR: In this article, a very rare case of malignant melanoma arising on a female nipple was reported, where a 42-year-old housewife had suffered from a small dark brown nevus on her left nipple for about thirty years without any changes.
Journal ArticleDOI
Enantioface-differentiating (asymmetric) addition of alkyllithium to aldehydes by using (2s, 2′s)-2-hydroxymethyl-1-[(1-methylpyrrolidin-2-yl)methyl] pyrrolidine as chiral ligand
TL;DR: Optically active alcohols are produced in good optical yields by treating aromatic and aliphatic aldehydes with alkyllithium by using (2S, 2′S)-2-hydroxymethyl-1-[(1-methylpyrrolidin-2-yl)methyl] pyrrolidine as chiral ligand.
Journal ArticleDOI
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Hiroki Izumi,Shingo Matsumoto,Jie Liu,Kosuke Tanaka,Shunta Mori,Kumiko Hayashi,Shogo Kumagai,Yuji Shibata,Takuma Hayashida,Kana Watanabe,Tatsuro Fukuhara,Takaya Ikeda,Kiyotaka Yoh,Terufumi Kato,Kazumi Nishino,Atsushi Nakamura,Ichiro Nakachi,Shoichi Kuyama,Naoki Furuya,Jun Sakakibara-Konishi,Isamu Okamoto,Kageaki Taima,Noriyuki Ebi,Haruko Daga,Akira Yamasaki,Masahiro Kodani,Hibiki Udagawa,Keisuke Kirita,Yoshitaka Zenke,Kaname Nosaki,Eri Sugiyama,Tetsuya Sakai,Tokiko Nakai,Genichiro Ishii,Seiji Niho,Atsushi Ohtsu,Susumu Kobayashi,Susumu Kobayashi,Koichi Goto +38 more
TL;DR: In this article, the authors identify a novel fusion transcript of CLIP1 and LTK using whole-transcriptome sequencing in a multi-institutional genome screening platform (LC-SCRUM-Asia, UMIN000036871).